Advertisement

Topics

Medi tech Group Company Profile

04:49 EST 17th December 2018 | BioPortfolio

Medi tech Group, having 2 daughter companies, MD and CMS, founded in 1998, is a group dedicated to provide state-of-the-art products with top-ranking quality and upstanding reputation. As a good provider and professional exporter whose products are sold to all over the world and experiences are abundant and various, we believe that during the days of globalization, facing the conflict of different cultures and customs, the most important thing for running business internationally is to be considerate, modest, creative, steadfast, passional and industrious.

Location

202, 118th Xuzhou Rd
Qingdao
Shandong
China

Contact

Phone: 86-532-85832673
Fax: 86-532-85832155
Email: sales@meditech.cn


News Articles [1318 Associated News Articles listed on BioPortfolio]

Medi-tate raises $20m from Japanese co Olympus

Medi-tate has developed a product for treatment of benign prostate tumors.

Medi-Tate enrolls first 50 patients for second European study on iTind

Medi-Tate, a medical device company focused on addressing unmet needs in the field of urology, today announced the enrollment of the first fifty patients in its second multi-center The post Medi-Tate...

Medi-Cal Telehealth Proposal Called ‘Remarkable Step Forward’

David Raths, Contributing EditorThe California Department of Health Care Services (DHCS) is proposing significant changes to its telehealth policy in the state’s Medicaid program known as Medi-Cal.

BTG buys Irish med device group Novate

Specialist healthcare group BTG has snapped up med tech group Novate Medical in a deal potentially worth $150 million.

Clanwilliam Group acquires NHS tech provider Informatica Systems in global expansion

An NHS technology provider that helps GPs to predict when specific patients are at risk of developing chronic diseases, and that allows planners to track... The post Clanwilliam Group acquires NHS tec...

Google hires Geisinger CEO as new health strategy leader

Google has hired Geisinger Health CEO David Feinberg to provide strategic leadership as the tech giant moves into the health sector. In a statement the Pennsylvania-based health firm Geisinger said F...

Tech Talk: How pharma manufacturers can go digital

In this feature of Tech Talk, Dr Neil Polwart, Novarum founder and BBI Group head of mobile discusses how pharmaceutical manufacturers can go digital using only their smartphones.

CompTIA Tech Summit set for October 17-18

Formerly known as the State Tech Summit, the 2018 Tech Summit will expand the conversation on the nexus between public policy and innovation by cutting Read more...

Drugs and Medications [199 Associated Drugs and Medications listed on BioPortfolio]

Denti-care denti-rinse [AR Medicom Inc]

Denti-Care Denti-Rinse 2 % Neutral Sodium Fluoride Oral Rinse Berry

Denti-care denti-rinse [AR Medicom Inc]

Denti-Care Denti-Rinse 2 % Neutral Sodium Fluoride Oral Rinse Mint

Denti-care denti-freeze [AR Medicom Inc]

Denti-Care Denti-Freeze Topical Anesthetic Gel Strawberry

Denti-care denti-freeze [AR Medicom Inc]

Denti-Care Denti-Freeze Topical Anesthetic Gel Raspberry

Mckesson medi-pak sterile [McKesson Medical-Surgical]

Drug Facts

PubMed Articles [1774 Associated PubMed Articles listed on BioPortfolio]

Morphology-adaptive total variation for the reconstruction of quantitative susceptibility map from the magnetic resonance imaging phase.

Quantitative susceptibility mapping (QSM) is a magnetic resonance imaging technique that quantifies the magnetic susceptibility distribution within biological tissues. QSM calculates the underlying ma...

Phonation Quotient Using Three Aerodynamic Instruments in the Disordered Voice.

The purpose of this study was to examine measures of phonation quotient (PQ) in two groups of persons with voice disorders using three different aerodynamic instruments representing low-tech and high-...

The San Diego 2007 wildfires and Medi-Cal emergency department presentations, inpatient hospitalizations, and outpatient visits: An observational study of smoke exposure periods and a bidirectional case-crossover analysis.

The frequency and intensity of wildfires is anticipated to increase as climate change creates longer, warmer, and drier seasons. Particulate matter (PM) from wildfire smoke has been linked to adverse ...

Quantitative susceptibility mapping using deep neural network: QSMnet.

Deep neural networks have demonstrated promising potential for the field of medical image reconstruction, successfully generating high quality images for CT, PET and MRI. In this work, an MRI reconstr...

Hi-tech restoration by two steps biocleaning process of Triumph of Death fresco at the Camposanto Monumental Cemetery (Pisa, Italy).

In this work, the "hi-tech" complex biocleaning and restoration of the 14th-century fresco Triumph of Death (5.6x15.0 m) at the Camposanto Monumental Cemetery (Pisa, Italy) is reported. Since 2000, th...

Clinical Trials [4245 Associated Clinical Trials listed on BioPortfolio]

A Study of the Safety and Tolerability of MEDI-570 (Experimental Drug) in Systemic Lupus Erythematosus

The purpose of this study is to evaluate the safety and tolerability of MEDI-570 in adult subjects with moderately to severely active systemic lupus erythematosus (SLE).

Safety and Tolerability of MEDI-545 in Patients Who Have Systemic Lupus Erythematosus (SLE)

The primary objective of this study is to evaluate the safety and tolerability of intravenously administered MEDI-545 compared with placebo, over a dose escalation range of 0.3-30 mg/kg, i...

Study of MEDI 507 in the Treatment of Pediatric Patients

To assess the safety of escalating dose levels of MEDI-507 in pediatric stem cell and bone marrow allograft recipients who have at least Grade II GvHD.

A Phase II Study of MEDI-507, Administered by Injection to Adults With Psoriasis

To compare disease activity, as measured by PASI score, of three MEDI-507 dosing (injection)regimens vs. placebo.

Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Single-Dose Subcutaneous Administration of MEDI-528

A Phase I studyto evaluate the safety and tolerability of escalating subcutaneous (SC) doses of MEDI-528 in to healthy adult volunteers.

Companies [2080 Associated Companies listed on BioPortfolio]

Medi tech Group

Medi tech Group, having 2 daughter companies, MD and CMS, founded in 1998, is a group dedicated to provide state-of-the-art products with top-ranking quality and upstanding reputation. As a good provi...

Medi-Span

Medi-Span is the leading provider of drug information for thousands of health care professionals worldwide. With more than 30 years experience, Medi-Span continues to offer author...

The Tech Group, Inc.

The Tech Group is a global leader in injection molding offering contract manufacturing solutions for the medical and consumer industries. Our aggressive and continual investment in technology is our c...

Tech Briefs Media Group

The Tech Briefs Media Group is publisher of NASA Tech Briefs, the largest-circulation design-engineering magazine worldwide and Defense Tech Briefs, the largest-circulation engineering magazine fo...

Finn-Medi Research

Finn-Medi Research was established in 1995 and it is owned by Finnvera, the Hospital District of Pirkanmaa, the Finnish National Fund for Research and Development (SITRA), Finnish Red Cross, City of T...

More Information about "Medi tech Group" on BioPortfolio

We have published hundreds of Medi tech Group news stories on BioPortfolio along with dozens of Medi tech Group Clinical Trials and PubMed Articles about Medi tech Group for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Medi tech Group Companies in our database. You can also find out about relevant Medi tech Group Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record